Total Payments
$78,799
2024 Payments
$3,459
Companies
41
Transactions
1,005
Medicare Patients
9,068
Medicare Billing
$969,976
Payment Breakdown by Category
Research$51,700 (65.6%)
Food & Beverage$20,266 (25.7%)
Consulting$2,660 (3.4%)
Other$2,450 (3.1%)
Travel$1,427 (1.8%)
Education$296.25 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $51,700 | 4 | 65.6% |
| Food and Beverage | $20,266 | 973 | 25.7% |
| Consulting Fee | $2,660 | 3 | 3.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,450 | 2 | 3.1% |
| Travel and Lodging | $1,427 | 6 | 1.8% |
| Education | $296.25 | 17 | 0.4% |
Payments by Type
Research
$51,700
4 transactions
General
$27,099
1,001 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $52,681 | 16 | $0 (2023) |
| Siemens Medical Solutions USA, Inc. | $4,360 | 4 | $0 (2024) |
| Boston Scientific Corporation | $3,883 | 79 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,520 | 231 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,088 | 93 | $0 (2024) |
| Amarin Pharma Inc. | $1,987 | 106 | $0 (2022) |
| Amgen Inc. | $1,850 | 83 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,377 | 56 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $1,235 | 40 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $926.90 | 49 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,459 | 78 | Siemens Medical Solutions USA, Inc. ($1,020) |
| 2023 | $10,043 | 104 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($5,526) |
| 2022 | $3,528 | 130 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($836.59) |
| 2021 | $39,311 | 161 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($36,735) |
| 2020 | $3,358 | 141 | Siemens Medical Solutions USA, Inc. ($1,140) |
| 2019 | $3,675 | 133 | Boston Scientific Corporation ($1,606) |
| 2018 | $3,213 | 134 | BOSTON SCIENTIFIC CORPORATION ($1,462) |
| 2017 | $12,211 | 124 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($9,510) |
All Payment Transactions
1,005 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Cardio-renal | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $38.32 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: Cardio-renal | ||||||
| 11/07/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | Siemens Medical Solutions USA, Inc. | ACUSON Origin Diagnostic Ultrasound System (Device) | Consulting Fee | Cash or cash equivalent | $1,020.00 | General |
| Category: US - Ultrasound Systems | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 10/18/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $146.59 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: Cardio-renal | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/02/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: Cardiology | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: Cardio-renal | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: Obesity | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | Azurity Pharmaceuticals, Inc. | EDARBYCLOR (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| MAPS | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $36,700 | 1 |
| Wearable Cardioverter Defibrillator in Hemodialysis Patients | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $9,500 | 1 |
| MAPS II | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $5,500 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,961 | 2,681 | $689,895 | $203,984 |
| 2022 | 23 | 1,911 | 2,631 | $664,813 | $206,694 |
| 2021 | 25 | 2,521 | 3,364 | $787,148 | $268,637 |
| 2020 | 28 | 2,675 | 3,450 | $898,223 | $290,661 |
Total Patients
9,068
Total Services
12,126
Medicare Billing
$969,976
Procedure Codes
103
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 230 | 407 | $116,928 | $40,456 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 247 | 439 | $89,061 | $29,327 | 32.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 151 | 178 | $103,774 | $28,879 | 27.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 141 | 141 | $73,320 | $22,471 | 30.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 95 | 132 | $52,338 | $18,994 | 36.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 56 | 181 | $30,951 | $11,872 | 38.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 67 | 74 | $34,114 | $9,681 | 28.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 113 | 118 | $26,196 | $6,195 | 23.7% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 84 | 102 | $39,066 | $5,882 | 15.1% |
| 99236 | Initial hospital care with same-day admission and discharge with high level of medical decision making, per day, if using time, at least 85 minutes | Facility | 2023 | 20 | 22 | $11,638 | $3,862 | 33.2% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 30 | 49 | $10,143 | $3,524 | 34.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 19 | 19 | $8,759 | $3,416 | 39.0% |
| 93268 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | Office | 2023 | 17 | 19 | $16,131 | $3,158 | 19.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 52 | 52 | $23,400 | $3,026 | 12.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 12 | 12 | $11,880 | $2,861 | 24.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 378 | 437 | $10,255 | $2,529 | 24.7% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 26 | 50 | $6,800 | $2,245 | 33.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 38 | 57 | $10,431 | $1,977 | 19.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 23 | 28 | $4,452 | $1,503 | 33.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 52 | 52 | $3,952 | $823.69 | 20.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 52 | 52 | $2,600 | $538.20 | 20.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 33 | 35 | $2,310 | $408.74 | 17.7% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 13 | 13 | $1,261 | $324.39 | 25.7% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 12 | 12 | $135.00 | $30.84 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 254 | 457 | $130,704 | $45,278 | 34.6% |
About Daniel Gottlieb, MD PS
Daniel Gottlieb, MD PS is a Cardiovascular Disease healthcare provider based in Burien, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1790778793.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Gottlieb, MD PS has received a total of $78,799 in payments from pharmaceutical and medical device companies, with $3,459 received in 2024. These payments were reported across 1,005 transactions from 41 companies. The most common payment nature is "" ($51,700).
As a Medicare-enrolled provider, Gottlieb has provided services to 9,068 Medicare beneficiaries, totaling 12,126 services with total Medicare billing of $969,976. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Burien, WA
- Active Since 08/24/2005
- Last Updated 06/26/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1790778793
Products in Payments
- LifeVest (Device) $52,681
- WATCHMAN (Device) $3,100
- ENTRESTO (Drug) $2,088
- Vascepa (Drug) $1,987
- ACUSON Sequoia Diagnostic Ultrasound System (Device) $1,700
- SC2000 (Device) $1,640
- BRILINTA (Drug) $1,431
- XARELTO (Drug) $1,377
- Repatha (Biological) $1,368
- Kerendia (Drug) $1,235
- ACUSON Origin Diagnostic Ultrasound System (Device) $1,020
- ELIQUIS (Drug) $819.34
- Impella (Device) $596.79
- FARXIGA (Drug) $589.96
- JARDIANCE (Drug) $508.04
- Corlanor (Drug) $481.32
- VERQUVO (Drug) $464.70
- LEQVIO (Drug) $422.61
- PRADAXA (Drug) $362.35
- SAMSCA (Drug) $339.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Burien
Lei Gao, Md, MD
Cardiovascular Disease — Payments: $2,637
Cardiovascular Disease $2,637
Siri Napan, M.d, M.D
Cardiovascular Disease — Payments: $396.84
Cardiovascular Disease $396.84
Bert Green, Md, MD
Cardiovascular Disease
Cardiovascular Disease
Sherry Parker, Rn, RN
Cardiovascular Disease
Cardiovascular Disease